Please check your internet connection and try again.
# Acetylcysteine
## Overview
Acetylcysteine is a mucolytic agent that breaks disulfide bonds in mucoproteins, reducing mucus viscosity. It also acts as an antidote for acetaminophen overdose by replenishing hepatic glutathione stores.
## Primary Indications
* **Acetaminophen Overdose:** Treatment to prevent or reduce liver injury.
* **Mucolytic Agent:** To thin thick mucus secretions in respiratory conditions (e.g., cystic fibrosis, COPD, pneumonia).
## Adult Dosing
### Acetaminophen Overdose
* **Intravenous (IV):**
* **Loading Dose:** 150 mg/kg IV over 1 hour.
* **Second Infusion:** 50 mg/kg IV over 16 hours.
* **Third Infusion:** 100 mg/kg IV over 16 hours (total duration 20 hours).
* **Maximum Total Dose:** Not to exceed 300 mg/kg for the entire treatment course.
* **Oral:**
* **Loading Dose:** 140 mg/kg PO.
* **Subsequent Doses:** 70 mg/kg PO every 4 hours for 17 doses (total 18 doses).
* **Maximum Dose:** 140 mg/kg per dose for loading, 70 mg/kg per dose thereafter.
### Mucolytic Agent
* **Nebulized:** 10% solution: 6 mL TID; or 20% solution: 3-5 mL TID.
* **Oral:** 200 mg PO BID to TID. Higher doses (e.g., up to 1200 mg/day) may be used in specific conditions like cystic fibrosis, often guided by institutional protocols.
## Pediatric Dosing
### Acetaminophen Overdose
* **Intravenous (IV):** Same as adult dosing (150 mg/kg over 1 hour, then 50 mg/kg over 16 hours, then 100 mg/kg over 16 hours). Dose calculated based on weight.
* **Oral:** Same as adult dosing (140 mg/kg PO loading, then 70 mg/kg PO every 4 hours for 17 doses).
### Mucolytic Agent
* **Nebulized:**
* Premature infants and infants: 10% solution 1-2 mL q4-6h; 20% solution 1-2 mL q4-6h.
* Children: 10% solution 3-5 mL TID; 20% solution 3 mL TID.
* **Oral:** Typically 600 mg/day divided into 2 or 3 doses for children over 14 years. Dosing for younger children is less established and may vary.
## Dose Adjustments
* **Renal Impairment:** No specific dose adjustment is typically recommended, but caution is advised.
* **Hepatic Impairment:** No specific dose adjustment is typically recommended for overdose treatment, but monitoring is crucial.
## Contraindications
* Known hypersensitivity to acetylcysteine or its components.
* Active gastric ulcer disease (for oral administration).
## Adverse Effects
* **Nebulized:** Bronchospasm (especially in asthmatics), stomatitis, nausea, vomiting, rhinorrhea.
* **Intravenous (for overdose):** Anaphylactoid reactions (rash, pruritus, urticaria, angioedema, bronchospasm, dyspnea, hypotension) are the most serious, typically occurring during the initial loading dose. Nausea and vomiting are common.
* **Oral:** Nausea, vomiting, diarrhea, rash.
## Key Drug Interactions
* **Activated Charcoal:** May adsorb oral acetylcysteine, reducing its absorption. Separate administration by at least 1 hour.
* **Nitroglycerin:** Potentiated hypotensive effect.
## Monitoring
* **Acetaminophen Overdose:**
* Serum acetaminophen levels and nomogram at appropriate time points.
* Liver function tests (AST, ALT, bilirubin, PT/INR) every 12-24 hours.
* Renal function and electrolytes.
* Clinical signs of liver injury.
* Monitor for anaphylactoid reactions during IV infusion.
* **Mucolytic Agent:**
* Pulmonary function tests.
* Sputum viscosity and clearance.
* Monitor for bronchospasm.
## Clinical Pearls
* For IV acetaminophen overdose, prompt